Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-25-004280
Filing Date
2025-07-29
Accepted
2025-07-29 17:55:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4409
  Complete submission text file 0001085146-25-004280.txt   6246
Mailing Address 101 JEFFERSON DRIVE MENLO PARK CA 94025
Business Address 101 JEFFERSON DRIVE MENLO PARK CA 94025 6503525600
SAGE RHINO CAPITAL LLC (Filed by) CIK: 0001771605 (see all company filings)

EIN.: 823527027 | State of Incorp.: CA | Fiscal Year End: 1231

Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Subject) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91457 | Film No.: 251163287
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)